Response Letter: Radiation therapy for COVID-19 pneumopathy.
Publication
, Journal Article
Kirsch, DG; Diehn, M; Cucinotta, FA; Weichselbaum, R
Published in: Radiother Oncol
August 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Radiother Oncol
DOI
EISSN
1879-0887
Publication Date
August 2020
Volume
149
Start / End Page
238 / 239
Location
Ireland
Related Subject Headings
- SARS-CoV-2
- Pneumonia, Viral
- Pandemics
- Oncology & Carcinogenesis
- Humans
- Coronavirus Infections
- COVID-19
- Betacoronavirus
- 5105 Medical and biological physics
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Kirsch, D. G., Diehn, M., Cucinotta, F. A., & Weichselbaum, R. (2020). Response Letter: Radiation therapy for COVID-19 pneumopathy. Radiother Oncol, 149, 238–239. https://doi.org/10.1016/j.radonc.2020.05.048
Kirsch, David G., Maximilian Diehn, Francis A. Cucinotta, and Ralph Weichselbaum. “Response Letter: Radiation therapy for COVID-19 pneumopathy.” Radiother Oncol 149 (August 2020): 238–39. https://doi.org/10.1016/j.radonc.2020.05.048.
Kirsch DG, Diehn M, Cucinotta FA, Weichselbaum R. Response Letter: Radiation therapy for COVID-19 pneumopathy. Radiother Oncol. 2020 Aug;149:238–9.
Kirsch, David G., et al. “Response Letter: Radiation therapy for COVID-19 pneumopathy.” Radiother Oncol, vol. 149, Aug. 2020, pp. 238–39. Pubmed, doi:10.1016/j.radonc.2020.05.048.
Kirsch DG, Diehn M, Cucinotta FA, Weichselbaum R. Response Letter: Radiation therapy for COVID-19 pneumopathy. Radiother Oncol. 2020 Aug;149:238–239.
Published In
Radiother Oncol
DOI
EISSN
1879-0887
Publication Date
August 2020
Volume
149
Start / End Page
238 / 239
Location
Ireland
Related Subject Headings
- SARS-CoV-2
- Pneumonia, Viral
- Pandemics
- Oncology & Carcinogenesis
- Humans
- Coronavirus Infections
- COVID-19
- Betacoronavirus
- 5105 Medical and biological physics
- 3211 Oncology and carcinogenesis